Streetbeat News

Stock Prices

GWW

W.W. Grainger's shares are trading lower following the company's Q2 earnings report, which revealed worse-than-expected revenues.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 3:31 pm

UDR

UDR Inc. reported lower than expected Q2 revenue results, leading to a decrease in its share price.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 3:30 pm

LIN

Over the past 10 years, Linde (NYSE:LIN) has outperformed the market by 1.89% on an annualized basis, producing an average annual return of 12.38%. If an investor had bought $1000 of LIN stock 10 years ago, it would be worth $3,198.21 today.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 3:30 pm

BX

Blackstone (NYSE:BX) has outperformed the market over the past 15 years, producing an average annual return of 12.38%. If an investor had bought $100 of BX stock 15 years ago, it would be worth $569.28 today.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 3:30 pm

SKIN

An option alert has been issued for Beauty Health (SKIN) for August 18 $9 calls. The sweep was near the ask with 600 @ $0.55 versus an open interest of 401. The company's earnings were released on August 9 before the market opened. The reference price was $8.56.

Portfolio Pulse from Charles Gross

July 27, 2023 | 3:30 pm

PRZO

ParaZero Technologies Ltd. has announced the pricing of its initial public offering (IPO) of 1.95 million shares at $4.00 per share, expected to start trading on The Nasdaq Capital Market under the ticker symbol PRZO on July 27, 2023. The gross proceeds are expected to be $7.8 million. Aegis Capital Corp. has been granted a 45-day option to purchase up to 292,500 additional shares. The net proceeds will be used for R&D, marketing, sales, discharging certain debts, working capital, and possible future acquisitions.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 3:26 pm

NVDA

VICR

An under-the-radar derivative play related to Nvidia has seen a nearly 60% increase this week, according to CNBC Pro. The specific derivative or related asset is not mentioned in the provided excerpt.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 3:24 pm

MRSN

Mersana Therapeutics Inc's stock is plunging after the company announced that the UPLIFT clinical trial of upifitamab rilsodotin (UpRi) did not meet its primary endpoint. The company will now focus on next-generation ADC platforms and plans to complete the dose escalation portion of the Phase 1 clinical trial of XMT-1660 in 2023. Mersana's restructuring plan includes a wind-down of UpRi-related development activities. If data analyses enable the identification of a path forward for UpRi, the company will consider strategic alternatives for the asset, including partnering.

Portfolio Pulse from Vandana Singh

July 27, 2023 | 3:23 pm

EB

Shares of Eventbrite Inc (NYSE:EB) spiked ahead of the company’s quarterly report. KeyBanc Capital Markets analyst Justin Patterson upgraded the rating for Eventbrite from Sector Weight to Overweight, while keeping the price target unchanged at $14. Patterson predicts that the scaling of demand generation products will support more than 20% of the company’s annual revenue growth through 2025 and lead to meaningful margin expansion.

Portfolio Pulse from Priya Nigam

July 27, 2023 | 3:19 pm

AMD

LRCX

Shares of Advanced Micro Devices, Inc. (AMD) are trading higher following strong Q4 financial results from Lam Research. Lam Research reported Q4 adjusted earnings of $5.98 per share, surpassing the analyst consensus estimate of $5.07. However, this represents a 32.28% decrease compared to earnings of $8.83 per share from the same period last year. The company also reported quarterly sales of $3.21 billion, exceeding the analyst consensus estimate of $3.13 billion.

Portfolio Pulse from Henry Khederian

July 27, 2023 | 3:19 pm